---
schema_version: "secwatch.filing_event.v1"
accession: "0001636422-26-000031"
form_type: "8-K"
ticker: "HCAT"
cik: "0001636422"
company_name: "Health Catalyst, Inc."
filed_at: "2026-03-12T23:59:59+00:00"
generated_at: "2026-05-15T13:32:48.607879+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Health Catalyst reports Q4 revenue down 6% YoY; net loss widens to $91M

## Summary
- Full-year 2025 revenue $311.1M, up 1% YoY; Q4 revenue $74.7M, down 6% YoY.
- Q4 net loss $91.0M vs $20.7M in Q4 2024; full-year net loss $178.0M vs $69.5M.
- Adjusted EBITDA for full-year 2025 was $41.4M.
- CEO Ben Albert cited opportunities and areas for improvement; focused on long-term success.

## SEC filing metadata
- accession: 0001636422-26-000031
- form_type: 8-K
- ticker: HCAT
- cik: 0001636422
- company_name: Health Catalyst, Inc.
- filed_at: 2026-03-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636422/000163642226000031/0001636422-26-000031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636422/000163642226000031/hcat-20260312.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001636422-26-000031
- JSON: https://secwatch.observer/filing/0001636422-26-000031.json
- Plain text: https://secwatch.observer/filing/0001636422-26-000031.txt

## Key facts
- Earnings Releases
  Health Catalyst, Inc. reported the quarter ended December 31, 2025 results: revenue $ 74,679, net income $ (91,025).
  - Period: the quarter ended December 31, 2025
  - Revenue: $ 74,679
  - Net income: $ (91,025)
  - Result: reported results
  source text: Months Ended December 31, Year over Year Change 2025 2024 2025 2024 GAAP Financial Measures: (in thousands, except percentages) (in thousands, except percentages) Total revenue $ 74,679 $ 79,606 (6)% $ 311,136 $ 306,584 1% Gross profit $ 31,385 $ 28,618 10% $ 120,356 $ 114,503 5% Gross margin 42.0 % 35.9 % 38.7 % 37.3 % Net loss $ (91,025) $ (20,673) (340)% $
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636422/000163642226000031/0001636422-26-000031-index.htm
- Earnings Releases
  Health Catalyst, Inc. reported the year ended December 31, 2025 results: revenue $311.1 million, net income $ (177,974).
  - Period: the year ended December 31, 2025
  - Revenue: $311.1 million
  - Net income: $ (177,974)
  - Result: reported results
  source text: We closed 2025 with solid performance across our business, including total revenue of $311.1 million and Adjusted EBITDA of $41.4 million,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636422/000163642226000031/0001636422-26-000031-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.